CLINICAL_TRIALS ClinicalTrials.gov record update

Safety of Nebulised Delivery of BromAc® (Bromelain & Acetylcysteine) in Healthy Volunteers: a Potential Treatment for Severe COVID-19

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05220605
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:59.688804+00:00
Published At: 2022-09-15T00:00:00+00:00
Record Updated At: 2022-09-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["COVID-19 Pneumonia", "Bromelains Adverse Reaction", "Acetylcysteine Adverse Reaction", "Mucus; Plug", "COVID-19 Acute Respiratory Distress Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-09-15"
protocolSection.identificationModule.nctId: "NCT05220605"
protocolSection.identificationModule.officialTitle: "Safety of Nebulised Delivery of BromAc\u00ae (Bromelain \u0026 Acetylcysteine) in Healthy Volunteers: a Potential Treatment for Severe COVID-19"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.